This educational program consists of three presentations (video or text) on triglyceride-rich lipoproteins and their remnants .

This course consists of the following:

• Why focus on triglyceride-rich lipoproteins and their remnants? - Prof. Henry Ginsberg, MD – New York, NY, USA
• Triglyceride-rich lipoproteins and residual CV risk - Prof. Erik Stroes, MD, PhD – Amsterdam, The Netherlands
• Targeting TG-rich remnant lipoproteins - Prof. Daniel Gaudet, MD, PhD – Montreal, QC, Canada

How to obtain your CME certificate

• Watch the three 3 lectures or read the monographs, and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos (or reading the text), the learner should be able to:

• Describe drivers of lipid-associated residual CV risk (when LDL-c levels are at or below target goals)
• Explain the association between triglyceride-rich lipoproteins and CV risk
• Tell what triglyceride-rich lipoproteins remnants are and why they are atherogenic
• Give examples of novel therapies to lower triglyceride-rich lipoproteins
• Describe differences in mechanism of action of therapies to lower triglyceride-rich lipoproteins

Expert faculty

• Prof. Henry Ginsberg, MD – New York, NY, USA
• Prof. Erik Stroes, MD, PhD – Amsterdam, The Netherlands
• Prof. Daniel Gaudet, MD, PhD – Montreal, QC, Canada

Target audience

This educational activity is designed for all healthcare professionals with an interest in lipid-associated residual risk beyond LDL-c.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by unrestricted educational grants from Pfizer Inc.

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.